259 related articles for article (PubMed ID: 2122422)
1. The influence of enteral feedings on sustained-release theophylline absorption.
Plezia PM; Thornley SM; Kramer TH; Armstrong EP
Pharmacotherapy; 1990; 10(5):356-61. PubMed ID: 2122422
[TBL] [Abstract][Full Text] [Related]
2. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
3. Effect of an enteral nutrient formula on sustained-release theophylline absorption.
Bhargava VO; Schaaf LJ; Berlinger WG; Jungnickel PW
Ther Drug Monit; 1989 Sep; 11(5):515-9. PubMed ID: 2510372
[TBL] [Abstract][Full Text] [Related]
4. [The bioavailability of 4 sustained-release theophylline preparations from the Chilean market].
Biagini L; Zamora P; Chávez H; Saavedra I
Rev Med Chil; 1990 Nov; 118(11):1241-6. PubMed ID: 2152650
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
6. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
Valet SB; Schwartz RH; Brooks JG
Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
[TBL] [Abstract][Full Text] [Related]
8. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y
Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057
[TBL] [Abstract][Full Text] [Related]
9. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
10. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
11. Absorption of sustained-release theophylline tablets.
Fagerström PO; Heintz L
Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207
[TBL] [Abstract][Full Text] [Related]
12. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
Schulz HU; Steinijans VW; Gabel H
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of phenytoin acid and phenytoin sodium with enteral feedings.
Doak KK; Haas CE; Dunnigan KJ; Reiss RA; Reiser JR; Huntress J; Altavela JL
Pharmacotherapy; 1998; 18(3):637-45. PubMed ID: 9620116
[TBL] [Abstract][Full Text] [Related]
15. Absorption of theophylline from conventional and sustained-release tablets.
Mellstrand T; Svedmyr N; Fagerström PO
Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
[TBL] [Abstract][Full Text] [Related]
16. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
17. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
18. [Bioavailability of a delayed-action aminophylline preparation].
Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
[TBL] [Abstract][Full Text] [Related]
19. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
Brown DL; Maddux MS; Organek HW; Bauman JL
Arch Intern Med; 1983 Apr; 143(4):794-6. PubMed ID: 6838301
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
